🏪 States Move to Tighten Rules on Hemp and Cannabis Markets

Lawmakers in states such as Illinois and New Jersey are advancing new legislation aimed at tightening regulations on hemp‑derived products while reshaping broader cannabis markets, reflecting growing efforts to close regulatory gaps and align with evolving federal policy. In Illinois, proposals would introduce mandatory licensing for CBD manufacturers, restrict sales of certain hemp products and lower barriers for smaller cannabis operators by reducing fees and expanding possession limits. At the same time, states are increasing oversight of intoxicating hemp products, particularly around marketing, age restrictions and retail access, as regulators respond to rapid market growth and ongoing federal uncertainty. (CSP Daily News)

📈 Study Links Childhood Trauma and Combined Substance Use to Higher Depression Rates in College Students

A Texas A&M University study found that college students with histories of childhood trauma who also engage in simultaneous use of multiple substances, particularly combinations like alcohol, cannabis and stimulants, are significantly more likely to experience moderate to severe depressive symptoms. Surveying more than 2,100 students, researchers noted high rates of substance use, including over half reporting cannabis use and nearly a quarter engaging in combined alcohol and cannabis use, alongside nearly 45% showing notable depression levels. The findings suggest that trauma, substance use and mental health challenges are closely interconnected, underscoring the need for integrated prevention and treatment approaches within college health systems. (Texas A&M University)

❤️‍🩹 Federal Lawsuit Accuses Cannabis Companies of Hiding Health Risks from Consumers

A federal class‑action lawsuit alleges that cannabis companies across 13 states misled consumers by promoting unproven health benefits while failing to disclose known risks, including serious mental health effects such as psychosis. Plaintiffs claim the products were deceptively marketed as helping with issues like anxiety and sleep, causing consumers to overpay or purchase items they might have avoided if fully informed. The case underscores growing scrutiny of the industry’s marketing practices and escalating concerns about potential health impacts tied to regular cannabis use, including conditions like cannabis hyperemesis syndrome and links to psychiatric disorders.

👉 Read The Full Study Here

⚠️ Debate Grows Over Labeling Hemp and Cannabis as Medicine Amid Safety Concerns

A Yahoo Finance article raises concerns about the growing trend of marketing hemp and cannabis products as “medicine,” warning that many products may not meet the rigorous manufacturing, testing and safety standards required for pharmaceuticals. It highlights risks such as potential contamination from pesticides, mycotoxins and inconsistent lab reporting, as well as gaps in research around long‑term health effects identified by regulators and scientific reviews. The discussion comes as federal policy shifts, including rescheduling and Medicare-related initiatives, bring cannabis closer to mainstream healthcare, intensifying scrutiny over quality control and the need for clearer regulatory oversight. (Yahoo!Finance)

🗓️ Continued Cannabis News & Events

• How Cannabis Compounds May Help Create Weight-Loss Drugs

• The Single Biggest Cannabis Catalyst in Years Is Rapidly Approaching: 2 Marijuana Stocks to Buy Now

• NC officials raise concerns about marijuana-impaired driving enforcement

• AI Is Growing Your Weed Now